Acetylsalicylic acid (aspirin) achieves its analgesic and antipyretic effects primarily through inhibition of cyclooxygenase (COX) enzymes.
- COX-1 inhibition: This leads to reduced production of thromboxane A2, a potent platelet aggregator, and prostaglandins involved in inflammation and pain signaling throughout the body. This explains aspirin’s anti-inflammatory and analgesic actions. COX-2 inhibition: Aspirin also inhibits COX-2, another enzyme involved in prostaglandin synthesis. COX-2 is predominantly expressed at sites of inflammation, contributing to pain and fever. Inhibition of COX-2 further enhances the analgesic and anti-inflammatory effects.
The reduced prostaglandin production from both COX-1 and COX-2 pathways has several consequences:
Pain relief: Prostaglandins sensitize pain receptors, making them more responsive to stimuli. By reducing prostaglandin levels, aspirin lowers pain perception. Fever reduction: Prostaglandins in the hypothalamus influence the body’s thermoregulatory set point. Aspirin’s inhibition of prostaglandin production lowers this set point, resulting in decreased body temperature.
It’s crucial to note the differing selectivity of various NSAIDs. While aspirin irreversibly inhibits COX enzymes, others, such as ibuprofen, are reversible inhibitors.
The specific contribution of COX-1 versus COX-2 inhibition to aspirin’s analgesic and antipyretic effects remains an area of ongoing research, with varying perspectives in the scientific literature. However, the overall effect is undeniable: aspirin reliably reduces pain and fever by modulating prostaglandin production.
